# BreastCancer-ClinicalTrial-Sim  
An R-based pipeline for simulating a randomized controlled trial (RCT) comparing immunotherapy versus chemotherapy in HR+/HER2− metastatic breast cancer. This pipeline includes data simulation, power analysis, survival modeling, subgroup assessment, and reproducible reporting.

## Summary  
1. Simulate baseline demographics, treatment allocation, and survival outcomes for a breast cancer patient group 
2. Estimate sample size required to detect a survival benefit using Schoenfeld’s method  
3. Analyze overall and progression-free survival with Kaplan-Meier curves and median survival estimates  
4. Fit Cox proportional hazards models, including stratified subgroup hazard ratios  
5. Generate subgroup-specific survival curves for ECOG status, hormone receptor status, and menopausal state  
6. Perform log-rank tests and test for treatment-by-subgroup interactions  
7. Simulate and tabulate adverse event rates across treatment arms  
8. Compile key results, visualizations, and statistical summaries into an HTML report

## Project Structure  
```
BreastCancerTrial_Sim/
├── scripts/                              # R scripts for simulation and analysis
│   ├── 01_simulate_breast_cancer_data.R    # Simulate trial cohort data
│   ├── 02_sample_size_calc.R               # Schoenfeld sample size estimation
│   ├── 03_kaplan_meier_analysis.R          # KM survival curves + median survival
│   ├── 04_cox_model_subgroup.R             # Cox model + subgroup HRs
│   ├── 05_subgroup_km_curves.R             # KM plots for ECOG, HR status, menopause
│   ├── 06_logrank_interaction_tests.R      # Log-rank tests + interaction p-values
│   ├── 07_subgroup_km_plots.R              # Forest and subgroup plots
│   └── 08_generate_summary.R               # Combine results into HTML report
│
├── results/                                # Output figures, tables, and HTML summary report
│   ├── figures/
│   │   ├── km_os_curve.png
│   │   ├── km_os_curve_risktable.png
│   │   ├── forest_subgroups.png
│   │   ├── km_hr_positive.png
│   │   ├── km_hr_negative.png
│   │   └── subgroups/
│   │       ├── ecog_0_KM.png
│   │       ├── ecog_1_KM.png
│   │       ├── ecog_2_KM.png
│   │       ├── hr_label_HR+_KM.png
│   │       ├── hr_label_HR−_KM.png
│   │       ├── menopause_Pre_KM.png
│   │       └── menopause_Post_KM.png
│   ├── tables/
│   │   └── cox_model_summary.csv
│   └── summary_report.html
│
├── data/
│   └── simulated_clinical_data.csv         # Generated data file
│
├── clinical_sap.md                         # Statistical Analysis Plan (SAP)
├── README.md                               # Project overview and instructions
├── environment.yml                         # Conda environment for R
└── .gitattributes                          # Language detection config for GitHub
```

## Installation  

1. Clone the repository:
```bash
git clone https://github.com/yourusername/breast_cancer_trial_sim.git
cd breast_cancer_trial_sim
```

2. Create and activate a Conda environment:
```bash
conda create -n clinical_r r-base=4.3
conda activate clinical_r
```

3. Install R and required R packages:
```bash
Rscript install.packages(c("simstudy", "survival", "survminer", "ggplot2", "gtsummary", "data.table"))
```

> Alternatively, use provided `environment.yml` to build the environment with R and required packages.
```bash
conda env create -f environment.yml
conda activate clinical_r
```
---

## Running the Pipeline

Run each script sequentially from the `scripts/` directory. 
Output files will be saved to the `results/` folder.

---

### Step 1:  *SIMULATE CLINICAL DATA*  
```bash
Rscript 01_simulate_breast_cancer_data.R
```
**Output:**   
1. Full synthetic patient dataset
  
  ```simulated_clinical_data.csv```

---

### Step 2:  *ESTIMATE SAMPLE SIZE*  
```bash
Rscript 02_sample_size_calc.R
```

---

### Step 3:  *PERFORM KAPLAM-MEIER SURVIVAL ANALYSIS*  
```bash
Rscript scripts/03_kaplan_meier_analysis.R
```
**Output:**  
1. Kaplan-Meier plot for overall survival (km_os_curve.png)
   ![KM OS](results/figures/km_os_curve.png)  
2. Kaplan-Meier plot with risk table (km_os_curve_risktable.png)
   ![KM OS RT](results/figures/km_os_curve_risktable.png)  

---

### Step 4:  *COX MODEL AND SUBGROUP HAZARD RATIOS*  
```bash
Rscript 04_subgroup_analysis.R
```
**Outputs:**  
1. Hazard ratios for treatment and subgroups

   ```cox_model_summary.csv```

---

### Step 5: *GENERATE SUBGROUP-SPECIFIC KM CURVES*
```bash
Rscript scripts/05_subgroup_km_curves.R
```
**Output:**
Kaplan-Meier plots:
1. HR-positive patients  (km_hr_positive.png)
   ![KM HR P](results/figures/km_hr_positive.png)
2. HR-negative patients  (km_hr_negative.png)
   ![KM HR N](results/figures/km_hr_negative.png)
3. ECOG = 0  (ecog_0_KM.png)
   ![KM E0](results/figures/subgroups/ecog_0_KM.png)
4. ECOG = 1  (ecog_1_KM.png)
   ![KM E1](results/figures/subgroups/ecog_1_KM.png)
5. ECOG = 2  (ecog_2_KM.png)
   ![KM E2](results/figures/subgroups/ecog_2_KM.png)
6. Pre-menopausal patients  (menopause_Pre_KM.png)
   ![KM PreM](results/figures/subgroups/menopause_Pre_KM.png)
7. Post-menopausal patients  (menopause_Post_KM.png)
   ![KM PostM](results/figures/subgroups/menopause_Post_KM.png)

---

### Step 6: *LOG-RANK INTERACTION TESTS*
```bash
Rscript scripts/06_logrank_interaction_tests.R
```

**Output:**  
1. p-values for interaction by subgroup (console) 

---

### Step 7: *FOREST PLOT AND SUBGROUP VISUALIZATIONS*
```bash
Rscript scripts/07_subgroup_km_plots.R
```

**Output:**  
1. Forest plot of subgroup hazard ratios  (forest_subgroups.png)
   ![Forest Plot](results/figures/forest_subgroups.png)

---

### Step 8: *GENERATE HTML SUMMARY REPORT*
```bash
Rscript scripts/08_generate_summary.R
```

**Output:**  
1. Final report compiling figures, tables, and key results (summary_report.html)
   
  [Open summary_report.html](results/summary_report.html)

---

## Dataset  

This project uses **fully simulated clinical trial data** generated using the `simstudy` package. It mimics a double-arm, 1:1 randomized Phase II trial comparing chemotherapy vs. PD-1/PD-L1 immunotherapy in HR+/HER2− metastatic breast cancer. No real patient data used.

- **Arms:** Standard chemotherapy vs. PD-1/PD-L1 immunotherapy  
- **Sample Size:** n = 300 simulated patients  
- **Endpoints:** Overall Survival (OS), Progression-Free Survival (PFS), Adverse Events  
- **Stratification:** ECOG status, menopausal status, HR subgroup  

---

## Documentation  

See the [Statistical Analysis Plan (SAP)](clinical_sap.md) for methodology, rationale, and endpoint definitions.

---

## Notes  
- This project was developed on macOS using R 4.3+.
